Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1995; Volume 47,Issue 3
  • You have access
    Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
    H T Schambye, S A Hjorth, J Weinstock and T W Schwartz
    Molecular Pharmacology March 1995, 47 (3) 425-431;
  • You have access
    Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.
    S G Bacsi, S Reisz-Porszasz and O Hankinson
    Molecular Pharmacology March 1995, 47 (3) 432-438;
  • You have access
    Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism.
    P H Roseboom and D C Klein
    Molecular Pharmacology March 1995, 47 (3) 439-449;
  • You have access
    Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
    M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
    Molecular Pharmacology March 1995, 47 (3) 450-457;
  • You have access
    Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
    S Loric, L Maroteaux, O Kellermann and J M Launay
    Molecular Pharmacology March 1995, 47 (3) 458-466;
  • You have access
    Molecular cloning and expression of a human secretin receptor.
    D R Patel, Y Kong and S P Sreedharan
    Molecular Pharmacology March 1995, 47 (3) 467-473;
  • You have access
    Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
    I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
    Molecular Pharmacology March 1995, 47 (3) 474-479;
  • You have access
    Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.
    J H Perlman, L Laakkonen, R Osman and M C Gershengorn
    Molecular Pharmacology March 1995, 47 (3) 480-484;
  • You have access
    Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
    P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
    Molecular Pharmacology March 1995, 47 (3) 485-490;
  • You have access
    Nonopioid mechanism of morphine modulation of the activation of 5-hydroxytryptamine type 3 receptors.
    P Fan
    Molecular Pharmacology March 1995, 47 (3) 491-495;
  • You have access
    Sodium fluoride stimulates exocytosis at a late site of calcium interaction in stimulus-secretion coupling: studies with the RINm5F beta cell line.
    M Komatsu, A M McDermott and G W Sharp
    Molecular Pharmacology March 1995, 47 (3) 496-508;
  • You have access
    Heterologous desensitization of both phosphoinositide and Ca2+ signaling in SH-SY5Y neuroblastoma cells: a role for intracellular Ca2+ store depletion?
    G B Willars and S R Nahorski
    Molecular Pharmacology March 1995, 47 (3) 509-516;
  • You have access
    Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
    E Clementi, I Vecchio, C Sciorati and G Nisticò
    Molecular Pharmacology March 1995, 47 (3) 517-524;
  • You have access
    Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
    J A Smith, C Webb, J Holford and G M Burgess
    Molecular Pharmacology March 1995, 47 (3) 525-534;
  • You have access
    Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
    G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
    Molecular Pharmacology March 1995, 47 (3) 535-543;
  • You have access
    Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    S C Wall, H Gu and G Rudnick
    Molecular Pharmacology March 1995, 47 (3) 544-550;
  • You have access
    Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
    D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
    Molecular Pharmacology March 1995, 47 (3) 551-557;
  • You have access
    Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
    S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
    Molecular Pharmacology March 1995, 47 (3) 558-567;
  • You have access
    In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
    Molecular Pharmacology March 1995, 47 (3) 568-581;
  • You have access
    Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    T J Wilding and J E Huettner
    Molecular Pharmacology March 1995, 47 (3) 582-587;
  • You have access
    Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress.
    E Guillemare, M Lazdunski and E Honoré
    Molecular Pharmacology March 1995, 47 (3) 588-594;
  • You have access
    Zinc is a mixed antagonist of homomeric rho 1 gamma-aminobutyric acid-activated channels.
    Y Chang, J Amin and D S Weiss
    Molecular Pharmacology March 1995, 47 (3) 595-602;
  • You have access
    Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons.
    R Yu and M K Ticku
    Molecular Pharmacology March 1995, 47 (3) 603-610;
  • You have access
    Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
    A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
    Molecular Pharmacology March 1995, 47 (3) 611-623;
  • You have access
    Molecular mechanics explanation for the stereochemical and shape selectivity of B-DNA for "bay-region" carcinogens.
    L Von Szentpaly and I L Shamovsky
    Molecular Pharmacology March 1995, 47 (3) 624-629;
  • You have access
    Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
    C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
    Molecular Pharmacology March 1995, 47 (3) 630-635;
  • You have access
    Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
    H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
    Molecular Pharmacology March 1995, 47 (3) 636-646;
  • You have access
    Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
    N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
    Molecular Pharmacology March 1995, 47 (3) 647-653;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 3
1 Mar 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics